Jose Yuste
@yusteneumo
Followers
64
Following
15
Media
7
Statuses
46
Staff scientist at the Spanish Pneumococal Reference Laboratory (CNM-ISCIII). Vaccines, epidemiology, molecular pathogenesis and bacterial immunology.
Joined May 2023
0
3
9
Nuestra mochila del Típico ha llegado más lejos que la de @PepePediatre. La próxima edición tendrás competencia😊. @fedemartinon @Neumo_experto @yusteneumo. Lo firma La Montse!!😁.
2
3
8
📍 El uso de #vacunas conjugadas frente a #neumococo puede prevenir las infecciones en forma de biofilms. Investigación liderada desde el Centro Nacional de Microbiología del #ISCIII y el @CIBERES @CIBER_ISCIII. 📰 Más información en #NoticiasISCIII ➡️ https://t.co/JAidBaRvDh
0
5
12
¡Espeto de vacunas en la #AEVMálaga24! Las vacunas funcionan #VaccinesWork #AEVMalaga2024 @AEV_Vacunas
1
4
19
Really excited to share that our study is finally published in @Nature ! Longer post to follow but thanks so much to all of my co-authors, supervisors, the GPS consortium, and reviewers. @noemielefrancq @hsalje @StephenBentley5 @pneumowatch
nature.com
Nature - Mathematical modelling of 15 years of data from South Africa reveals the spread and vaccine-driven changes in fitness and antimicrobial resistance of Streptococcus pneumoniae.
12
35
129
I am pleased to share with all of you our last contribution to the evolution of Invasive Pneumococcal Disease in Spain. @SaludISCIII; @CIBERES; @Neumo_experto; @AEV_Vacunas
https://t.co/2l0LQA0YAe
journalofinfection.com
Dynamic trends of invasive pneumococcal disease (IPD) including the evolution of prevalent serotypes are very useful to evaluate the impact of current and future pneumococcal conjugate vaccines...
0
4
14
Finally out! See our latest manuscript: Surveillance of Invasive Pneumococcal Disease in Spain Exploring the Impact of the COVID-19 Pandemic (2019-2023) - Journal of Infection @miridome8 @yusteneumo @CoviPerez @SaludISCIII @CIBERES
journalofinfection.com
Dynamic trends of invasive pneumococcal disease (IPD) including the evolution of prevalent serotypes are very useful to evaluate the impact of current and future pneumococcal conjugate vaccines...
3
2
17
Apoya a #ABID @AfectadosBSS en la 🧪🧬🧫🔬🔭📡💉🧬💊🩼🩺🧪🧬🧫 CONCENTRACIÓN MADRID Sábado 18 de mayo Delante del Ministerio de Inclusión, Seguridad Social y Migraciones #YoInvestiguéSinCotizar #TimoConvenioS 🧪🧬🧫🔬🔭📡💉🧬💊🩼🩺🧪🧬🧫
5
147
160
Excited to share that our latest paper has just been published in @LancetRH_Europe ! Very grateful to all who made this work possible. Evolution of Serotype 3 IPD over three decades. @hbellvitge @CIBERES @idibell_cat @CampusBellvitge
https://t.co/kQwvNAtksH
1
11
30
We got accepted a paper that provides epidemiological and mechanistic insights into the worrisome increase of macrolide resistance in Spn strains. The review paper was CV-D’s @NSURPorg summer project while an undergrad. Carolina is now a grad student in Spain with @yusteneumo
1
4
28
New meningitis vaccine developed by the @TangLabOxford! The new chimeric protein-based #vaccine to tackle #MenB is the result of a strategic collaboration between @UniofOxford & @SerumInstIndia Find out more: https://t.co/ZeXM9G9dza
2
16
60
Proud of our PhD student Anna Scasny who will defend her Doctoral thesis next Monday 04/08/2024 at 3 pm CST @UMMCnews @GradSchoolUMMC. Join us right after her thesis defense at Fertile Ground Beer Co. at 5 pm to congratulate (assuming all goes fine) the new Doctor Scasny !
0
2
15
Enjoying the presentation of my PhD student Covadonga @CoviPerez at ISPPD-13 in South Africa showing the upsurge of serotype 3 in Spain. She did very very well. Congratulations. I am very proud of you.
0
3
10
Fantastic talk of my first PhD student Elisa @microelisa who is now a senior posdoc at UCL showing really interesting data at ISPPD in Cape Town. Well done Elisa. I am very proud of you.
2
2
10
Great day at ISPPD in South Africa (Cape Town). Today our posdoc Julio Sempere gave a fantastic talk @juliobioq. He has been selected as a finalist to obtain the young scientist award. I am really proud of you and my colleague @miridome8. Tomorrow more and better.
3
2
11
Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper https://t.co/AYe5nLiwXe
@Neumo_experto
1
6
15
Los extraordinarios biofilms bacterianos son causantes de muchas infecciones crónicas y daños en la industria alimentaria 🗣️ Hablamos de ellos con la bióloga Miriam Domenech (@BiologiaUcm @CIBERES) 📻 En 'A hombros de gigantes' con @searavalero
https://t.co/qt8kEexzYg
0
5
9
Magnífica ponencia del Dr. Manuel Baca sobre prevención del VRS en el congreso de la asociación española de vacunasAEV. @CIBERES @SaludISCIII @AEV_Vacunas
0
2
13